The FDA made a May recall by Boston Scientific Corp. (NYSE:BSX) of 500 of its Innova stents from customers overseas Class I, its most serious designation.
It’s the second Class I recall for the Natick, Mass.-based medical device giant posted last month, after pulling all 30,000 of its iCross coronary catheters.